robotics

CORPATH GRX benefits

Proven Patient & Provider Benefit

CorPath GRX is a second generation robotic-assisted system built on the foundation of the CorPath 200’s clinical success with over approximately 10,000 cases across more than 100 programs worldwide.

When using the CorPath System, studies have shown:*

clinical'
Clinical Success in Complex Cases

The PRECISION GRX registry demonstrated 98.2% clinical success of all treated lesions, and 99.1% clinical success in CTO cases1,2

 
Radiation Reduction to the Patient
Radiation Reduction to the Patient

A single center study published in Circulation: Cardiovascular Interventions demonstrated a 20% reduction in radiation dose to the patient compared to manual PCI.2

 
Stent Usage'
Reduction in Stent Usage

A recent study demonstrated that accurate measurement of coronary anatomy, using CorPath, reduced the use of unnecessary additional stents by 8.3%.3

 
radiation'
Radiation Reduction to Physicians

The PRECISE trial demonstrated a 95% reduction in radiation exposure to the primary operator.4

 

CorPath GRX Delivers Value

Procedural
Control

  • Increase control via robotic-assisted operation of the guide catheter, guidewire, and RX catheter
  • Enhance workflow with streamlined bedside features and simple device exchanges

Robotic
Precision

  • Position stents exactly where you need them with 1mm movements
  • Optimize stent selection and usage with sub-mm measurement

Radiation Safety in the Interventional Suite

  • Radiation-shielded workstation enables procedural control without wearing lead
  • Potential to minimize painful orthopedic injuries
 
 
 

1. Mahmud E, et al. Safety and Efficacy of the Second Generation Robotic-Assisted System for Percutaneous Coronary Intervention: Final Results of the Multicenter PRECISION GRX Study. SCAI. 2021.

2. CTO lesions: typically first crossed manually before initiating treatment with the CorPath GRX system

3. Campbell PT, et al. The Impact of Precise Robotic Lesion Length Measurement on Stent Length Selection: Ramification for stent savings. Cardiovasc Revasc Med. 2015;piii:S1553-8389.

4. Weisz G, et al. Safety and Feasibility of Robotic Percutaneous Coronary Intervention: PRECISE Study. J American College of Cardiol, 2013, Vol 61, No. 15: 1596-1600.

* Includes studies conducted using CorPath 200

 
 
close the window

Please complete the form below in order to download the content.








right
close the window

Please complete the form below in order to download the content.







close the window

Please complete the form below and a sales representative will contact you. By submitting this form, I consent to receive email communications from Corindus.








close the window

Please fill out this brief form to subscribe to our email newsletter. By submitting this form, I consent to receive email communications from Corindus.







close the window

Please fill out the form below and we will e-mail you the documents. By submitting this form, I consent to receive email communications from Corindus.






close the window

Please fill out this brief form to download the Article Summary. By submitting this form, I consent to receive email communications from Corindus.







close the window

Please complete the form below and a member of our Clinical team will contact you. By submitting this form, I consent to receive email communications from Corindus.









close the window

Please complete the form below in order to download the content.








close the window
close the window